Trevi Therapeutics Inc
TRVI
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.59B
Close$
$0.13
99.3% downside
Current Fair Value
99.3% downsideOvervalued by 99.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.59 Billion |
|---|---|
| Enterprise Value | $2.57 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.29 |
| Beta | 1 |
| Outstanding Shares | 145,592,901 |
Return
| Return on Equity | -26.50% |
|---|---|
| Return on Assets | -25.40% |
| Return on Invested Capital | -30.63% |
Valuation & Multiples
| P/E Ratio | -56.64 |
|---|---|
| PEG | -205.36 |
| Price to Sales | - |
| Price to Book Ratio | 18.25 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -48.68 |
| Enterprise Value to Net Income | -57 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 14, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 6, 2026
EPS Estimate
$-0.11
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 31.57% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 2.51%▼ 90.22% |
|---|---|
| Total Invested | $68.18M▼ 95.78% |
| Investors Holding | 25▼ 180.00% |
ESG Score
No data